Thomas Mair

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status

Mohamed E. Elsesy, Ayham Moustafa, Su-Jung Oh-Hohenhorst, Christian Müller et autres

Égypte, de, tr (code pays fourni par la source)

Monoallelic PSMB8 variants cause PRAAS with immunodeficiency through impaired immunoproteasome assembly

Robin Wijngaard, Caspar I. van der Made, Sema Kalkan Uçar, Gayatri Ramakrishnan et autres

nl, tr, de, us, au, it, at (code pays fourni par la source)

Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor–based radiosensitization

Sabrina Köcher, Mohamed E. Elsesy, Ayham Moustafa, Wahid Mohammadi et autres

de, pk, Égypte, fr, gb, tr (code pays fourni par la source)

CDKL1 variants affecting ciliary formation predispose to thoracic aortic aneurysm and dissection

Theresa Nauth, Melanie Philipp, Sina Renner, Martin D. Burkhalter et autres

de, cn, ca, fr, us, sk (code pays fourni par la source)

Thoracic aortic diseases: Identification of diagnostic biomarkers using proteomic analysis

Nico Arndt, Thomas Mair, Maria Riedner, Ali Biabani et autres

de, us (code pays fourni par la source)

Supplementary Table S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Tobias Busenbender, Dmitry N. Pelageev, Jessica Hauschild, Moritz Kaune et autres

Supplementary Methods S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Tobias Busenbender, Dmitry N. Pelageev, Jessica Hauschild, Moritz Kaune et autres

Supplementary Table S4 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Tobias Busenbender, Dmitry N. Pelageev, Jessica Hauschild, Moritz Kaune et autres

Supplementary Methods S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Tobias Busenbender, Dmitry N. Pelageev, Jessica Hauschild, Moritz Kaune et autres

Supplementary Figure S4 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Tobias Busenbender, Dmitry N. Pelageev, Jessica Hauschild, Moritz Kaune et autres

Supplementary Figure S3 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Tobias Busenbender, Dmitry N. Pelageev, Jessica Hauschild, Moritz Kaune et autres

Supplementary Table S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer

Tobias Busenbender, Dmitry N. Pelageev, Jessica Hauschild, Moritz Kaune et autres